Releases › ICD-10-PCS FY2024

ICD-10-PCS FY2024

Effective 2023-10-01 to 2024-09-30. 78,638 codes in the release.

124added

17revised

12removed

Codes added 124

Code	Description
00H005Z	Insertion of Radioactive Element, Palladium-103 Collagen Implant into Brain, Open Approach
02583ZF	Destruction of Conduction Mechanism using Irreversible Electroporation, Percutaneous Approach
02HW3RZ	Insertion of Short-term External Heart Assist System into Thoracic Aorta, Descending, Percutaneous Approach
02PW3RZ	Removal of Short-term External Heart Assist System from Thoracic Aorta, Descending, Percutaneous Approach
02WW3RZ	Revision of Short-term External Heart Assist System in Thoracic Aorta, Descending, Percutaneous Approach
07TP4ZG	Resection of Spleen, Percutaneous Endoscopic Approach, Hand-Assisted
097N0ZZ	Dilation of Nasopharynx, Open Approach
097N7ZZ	Dilation of Nasopharynx, Via Natural or Artificial Opening
097N8ZZ	Dilation of Nasopharynx, Via Natural or Artificial Opening Endoscopic
0CSS0ZZ	Reposition Larynx, Open Approach
0CSS7ZZ	Reposition Larynx, Via Natural or Artificial Opening
0CSS8ZZ	Reposition Larynx, Via Natural or Artificial Opening Endoscopic
0DBF4ZG	Excision of Right Large Intestine, Percutaneous Endoscopic Approach, Hand-Assisted
0DBG4ZG	Excision of Left Large Intestine, Percutaneous Endoscopic Approach, Hand-Assisted
0DBJ4ZG	Excision of Appendix, Percutaneous Endoscopic Approach, Hand-Assisted
0DBL4ZG	Excision of Transverse Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DBM4ZG	Excision of Descending Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DBN4ZG	Excision of Sigmoid Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DH17JZ	Insertion of Magnetic Lengthening Device into Upper Esophagus, Via Natural or Artificial Opening
0DH27JZ	Insertion of Magnetic Lengthening Device into Middle Esophagus, Via Natural or Artificial Opening
0DH37JZ	Insertion of Magnetic Lengthening Device into Lower Esophagus, Via Natural or Artificial Opening
0DTF4ZG	Resection of Right Large Intestine, Percutaneous Endoscopic Approach, Hand-Assisted
0DTG4ZG	Resection of Left Large Intestine, Percutaneous Endoscopic Approach, Hand-Assisted
0DTJ4ZG	Resection of Appendix, Percutaneous Endoscopic Approach, Hand-Assisted
0DTL4ZG	Resection of Transverse Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DTM4ZG	Resection of Descending Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DTN4ZG	Resection of Sigmoid Colon, Percutaneous Endoscopic Approach, Hand-Assisted
0DXU0ZV	Transfer Omentum to Thoracic Region, Open Approach
0DXU0ZW	Transfer Omentum to Abdominal Region, Open Approach
0DXU0ZX	Transfer Omentum to Pelvic Region, Open Approach
0DXU0ZY	Transfer Omentum to Inguinal Region, Open Approach
0DXU4ZV	Transfer Omentum to Thoracic Region, Percutaneous Endoscopic Approach
0DXU4ZW	Transfer Omentum to Abdominal Region, Percutaneous Endoscopic Approach
0DXU4ZX	Transfer Omentum to Pelvic Region, Percutaneous Endoscopic Approach
0DXU4ZY	Transfer Omentum to Inguinal Region, Percutaneous Endoscopic Approach
0FB04ZG	Excision of Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FB14ZG	Excision of Right Lobe Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FB24ZG	Excision of Left Lobe Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FBG4ZG	Excision of Pancreas, Percutaneous Endoscopic Approach, Hand-Assisted
0FT04ZG	Resection of Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FT14ZG	Resection of Right Lobe Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FT24ZG	Resection of Left Lobe Liver, Percutaneous Endoscopic Approach, Hand-Assisted
0FT44ZG	Resection of Gallbladder, Percutaneous Endoscopic Approach, Hand-Assisted
0FTG4ZG	Resection of Pancreas, Percutaneous Endoscopic Approach, Hand-Assisted
0TT04ZG	Resection of Right Kidney, Percutaneous Endoscopic Approach, Hand-Assisted
0TT14ZG	Resection of Left Kidney, Percutaneous Endoscopic Approach, Hand-Assisted
0TT24ZG	Resection of Bilateral Kidneys, Percutaneous Endoscopic Approach, Hand-Assisted
0WHC0GZ	Insertion of Defibrillator Lead into Mediastinum, Open Approach
0WHC3GZ	Insertion of Defibrillator Lead into Mediastinum, Percutaneous Approach
0WHC4GZ	Insertion of Defibrillator Lead into Mediastinum, Percutaneous Endoscopic Approach
0WPC0GZ	Removal of Defibrillator Lead from Mediastinum, Open Approach
0WPC3GZ	Removal of Defibrillator Lead from Mediastinum, Percutaneous Approach
0WPC4GZ	Removal of Defibrillator Lead from Mediastinum, Percutaneous Endoscopic Approach
0WPCXGZ	Removal of Defibrillator Lead from Mediastinum, External Approach
0WWC0GZ	Revision of Defibrillator Lead in Mediastinum, Open Approach
0WWC3GZ	Revision of Defibrillator Lead in Mediastinum, Percutaneous Approach
0WWC4GZ	Revision of Defibrillator Lead in Mediastinum, Percutaneous Endoscopic Approach
0WWCXGZ	Revision of Defibrillator Lead in Mediastinum, External Approach
3E0L317	Introduction of Other Thrombolytic into Pleural Cavity, Percutaneous Approach
5A09B5K	Assistance with Respiratory Ventilation, Less than 8 Consecutive Hours, Intubated Prone Positioning
5A09C5K	Assistance with Respiratory Ventilation, 8-24 Consecutive Hours, Intubated Prone Positioning
5A09D5K	Assistance with Respiratory Ventilation, Greater than 24 Consecutive Hours, Intubated Prone Positioning
8E0U0EN	Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Open Approach
8E0U3EN	Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Approach
8E0U4EN	Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Percutaneous Endoscopic Approach
8E0U7EN	Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening
8E0U8EN	Fluorescence Guided Procedure of Female Reproductive System using Pafolacianine, Via Natural or Artificial Opening Endoscopic
8E0W0EN	Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Open Approach
8E0W3EN	Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Approach
8E0W4EN	Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Percutaneous Endoscopic Approach
8E0W7EN	Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening
8E0W8EN	Fluorescence Guided Procedure of Trunk Region using Pafolacianine, Via Natural or Artificial Opening Endoscopic
X05	New Technology, Nervous System, Destruction
X051329	Destruction of Renal Sympathetic Nerve(s) using Ultrasound Ablation, Percutaneous Approach, New Technology Group 9
X2H	New Technology, Cardiovascular System, Insertion
X2H03R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Inferior Vena Cava, Percutaneous Approach, New Technology Group 9
X2H13R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Superior Vena Cava, Percutaneous Approach, New Technology Group 9
X2H20R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Right Femoral Vein, Open Approach, New Technology Group 9
X2H30R9	Insertion of Intraluminal Device, Bioprosthetic Valve into Left Femoral Vein, Open Approach, New Technology Group 9
X2H63V9	Insertion of Dual-Chamber Intracardiac Pacemaker into Right Atrium, Percutaneous Approach, New Technology Group 9
X2HK3V9	Insertion of Dual-Chamber Intracardiac Pacemaker into Right Ventricle, Percutaneous Approach, New Technology Group 9
X2HL0F9	Insertion of Conduit to Short-term External Heart Assist System into Right Axillary Artery, Open Approach, New Technology Group 9
X2HM0F9	Insertion of Conduit to Short-term External Heart Assist System into Left Axillary Artery, Open Approach, New Technology Group 9
X2HX0F9	Insertion of Conduit to Short-term External Heart Assist System into Thoracic Aorta, Ascending, Open Approach, New Technology Group 9
X2KH3D9	Bypass Right Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
X2KH3E9	Bypass Right Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
X2KJ3D9	Bypass Left Femoral Artery using Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach, New Technology Group 9
X2KJ3E9	Bypass Left Femoral Artery using Conduit through Femoral Vein to Popliteal Artery, Percutaneous Approach, New Technology Group 9
X2U	New Technology, Cardiovascular System, Supplement
X2U4079	Supplement Coronary Artery/Arteries with Vein Graft Extraluminal Support Device(s), Open Approach, New Technology Group 9
X2UQ0P9	Supplement Right Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
X2UR0P9	Supplement Left Upper Extremity Vein with Synthetic Substitute, Extraluminal Support Device, Open Approach, New Technology Group 9
XNHG0F9	Insertion of Tibial Extension with Motion Sensors into Right Tibia, Open Approach, New Technology Group 9
XNHH0F9	Insertion of Tibial Extension with Motion Sensors into Left Tibia, Open Approach, New Technology Group 9
XNR	New Technology, Bones, Replacement
XNR80D9	Replacement of Skull with Ultrasound Penetrable Synthetic Substitute, Open Approach, New Technology Group 9
XNRL099	Replacement of Right Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
XNRM099	Replacement of Left Tarsal with Talar Prosthesis Synthetic Substitute, Open Approach, New Technology Group 9
XRGJ0B9	Fusion of Right Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGK0B9	Fusion of Left Ankle Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGL0B9	Fusion of Right Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XRGM0B9	Fusion of Left Tarsal Joint using Open-truss Design Internal Fixation Device, Open Approach, New Technology Group 9
XW01329	Introduction of Talquetamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
XW013L9	Introduction of Elranatamab Antineoplastic into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
XW013S9	Introduction of Epcoritamab Monoclonal Antibody into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 9
XW033K9	Introduction of Sulbactam-Durlobactam into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033P9	Introduction of Glofitamab Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033Q9	Introduction of Posoleucel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW033R9	Introduction of Rezafungin into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW043K9	Introduction of Sulbactam-Durlobactam into Central Vein, Percutaneous Approach, New Technology Group 9
XW043P9	Introduction of Glofitamab Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 9
XW043Q9	Introduction of Posoleucel into Central Vein, Percutaneous Approach, New Technology Group 9
XW043R9	Introduction of Rezafungin into Central Vein, Percutaneous Approach, New Technology Group 9
XW053T9	Introduction of Melphalan Hydrochloride Antineoplastic into Peripheral Artery, Percutaneous Approach, New Technology Group 9
XW0DXJ9	Introduction of Quizartinib Antineoplastic into Mouth and Pharynx, External Approach, New Technology Group 9
XW0DXN9	Introduction of SER-109 into Mouth and Pharynx, External Approach, New Technology Group 9
XW133H9	Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
XW143H9	Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
XX2	New Technology, Physiological Systems, Monitoring
XX20X89	Monitoring of Brain Electrical Activity, Computer-aided Detection and Notification, New Technology Group 9
XX2F3W9	Monitoring of Musculoskeletal Muscle Compartment Pressure, Micro-Electro-Mechanical System, Percutaneous Approach, New Technology Group 9
XX2KXP9	Monitoring of Interstitial Fluid Volume, Sub-Epidermal Moisture using Electrical Biocapacitance, External Approach, New Technology Group 9
XXE2X19	Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9
XXE5XY9	Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9

Descriptions revised 17

Code	Was, and is now
5A0935A	~~Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, High Nasal Flow/Velocity~~ Assistance with Respiratory Ventilation, Less than 24 Consecutive Hours, High Flow/Velocity Cannula
5A0945A	~~Assistance with Respiratory Ventilation, 24-96 Consecutive Hours, High Nasal Flow/Velocity~~ Assistance with Respiratory Ventilation, 24-96 Consecutive Hours, High Flow/Velocity Cannula
5A0955A	~~Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, High Nasal Flow/Velocity~~ Assistance with Respiratory Ventilation, Greater than 96 Consecutive Hours, High Flow/Velocity Cannula
XRGA0R7	~~Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7~~ Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
XRGA3R7	~~Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7~~ Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
XRGA4R7	~~Fusion of Thoracolumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7~~ Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
XRGB0R7	~~Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7~~ Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
XRGB3R7	~~Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7~~ Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
XRGB4R7	~~Fusion of Lumbar Vertebral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7~~ Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
XRGC0R7	~~Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7~~ Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
XRGC3R7	~~Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7~~ Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
XRGC4R7	~~Fusion of 2 or more Lumbar Vertebral Joints using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7~~ Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
XRGD0R7	~~Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Open Approach, New Technology Group 7~~ Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7
XRGD3R7	~~Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Percutaneous Approach, New Technology Group 7~~ Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7
XRGD4R7	~~Fusion of Lumbosacral Joint using Customizable Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7~~ Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7
XW00X27	~~Introduction of Bromelain-enriched Proteolytic Enzyme into Skin, External Approach, New Technology Group 7~~ Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7
XW01X27	~~Introduction of Bromelain-enriched Proteolytic Enzyme into Subcutaneous Tissue, External Approach, New Technology Group 7~~ Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7

Codes removed 12

Code	Description
0X6L0Z2	Detachment at Right Thumb, Mid, Open Approach
0X6M0Z2	Detachment at Left Thumb, Mid, Open Approach
0Y6P0Z2	Detachment at Right 1st Toe, Mid, Open Approach
0Y6Q0Z2	Detachment at Left 1st Toe, Mid, Open Approach
GZB1ZZZ	Electroconvulsive Therapy, Unilateral-Multiple Seizure
GZB3ZZZ	Electroconvulsive Therapy, Bilateral-Multiple Seizure
XV5	New Technology, Male Reproductive System, Destruction
XV508A4	Destruction of Prostate using Robotic Waterjet Ablation, Via Natural or Artificial Opening Endoscopic, New Technology Group 4
XW033G4	Introduction of Plazomicin Anti-infective into Peripheral Vein, Percutaneous Approach, New Technology Group 4
XW033H4	Introduction of Synthetic Human Angiotensin II into Peripheral Vein, Percutaneous Approach, New Technology Group 4
XW043G4	Introduction of Plazomicin Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 4
XW043H4	Introduction of Synthetic Human Angiotensin II into Central Vein, Percutaneous Approach, New Technology Group 4